SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001771910-21-000010
Filing Date
2021-03-18
Accepted
2021-03-18 07:12:53
Documents
192
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F adc-20201231.htm   iXBRL 20-F 5368339
2 EX-2.1 ex21-descriptionofsecuriti.htm EX-2.1 100145
3 EX-4.3 ex43-amendedandrestatedcol.htm EX-4.3 210509
4 EX-4.4 ex44-overlandxadctspa.htm EX-4.4 248369
5 EX-4.5 ex45-overlandxadctsha.htm EX-4.5 536259
6 EX-4.6 ex46overland-adctlicensean.htm EX-4.6 409330
7 EX-4.18 ex418-amendmenttoregistrat.htm EX-4.18 36928
8 EX-4.19 ex419-uklease.htm EX-4.19 289274
9 EX-12.1 ex121-ceocertification302.htm EX-12.1 9441
10 EX-12.2 ex122-cfocertification302.htm EX-12.2 9572
11 EX-13.1 ex131-ceocertification906.htm EX-13.1 4606
12 EX-13.2 ex132-cfocertification906.htm EX-13.2 4717
13 EX-15.1 ex151-consent.htm EX-15.1 2043
19 adc-20201231_g1.jpg GRAPHIC 109670
20 adc-20201231_g10.jpg GRAPHIC 58061
21 adc-20201231_g11.jpg GRAPHIC 35136
22 adc-20201231_g12.jpg GRAPHIC 91414
23 adc-20201231_g13.jpg GRAPHIC 34126
24 adc-20201231_g14.jpg GRAPHIC 38111
25 adc-20201231_g15.jpg GRAPHIC 767668
26 adc-20201231_g16.jpg GRAPHIC 765031
27 adc-20201231_g17.jpg GRAPHIC 60883
28 adc-20201231_g18.jpg GRAPHIC 365593
29 adc-20201231_g19.jpg GRAPHIC 59347
30 adc-20201231_g2.jpg GRAPHIC 68341
31 adc-20201231_g20.jpg GRAPHIC 45908
32 adc-20201231_g21.jpg GRAPHIC 35439
33 adc-20201231_g22.jpg GRAPHIC 52167
34 adc-20201231_g23.jpg GRAPHIC 35395
35 adc-20201231_g24.jpg GRAPHIC 36393
36 adc-20201231_g25.jpg GRAPHIC 87313
37 adc-20201231_g26.jpg GRAPHIC 24042
38 adc-20201231_g27.jpg GRAPHIC 21315
39 adc-20201231_g28.jpg GRAPHIC 32718
40 adc-20201231_g29.jpg GRAPHIC 20927
41 adc-20201231_g3.jpg GRAPHIC 402415
42 adc-20201231_g30.jpg GRAPHIC 76336
43 adc-20201231_g31.jpg GRAPHIC 26753
44 adc-20201231_g32.jpg GRAPHIC 25096
45 adc-20201231_g33.jpg GRAPHIC 29619
46 adc-20201231_g4.jpg GRAPHIC 80485
47 adc-20201231_g5.jpg GRAPHIC 34795
48 adc-20201231_g6.jpg GRAPHIC 69657
49 adc-20201231_g7.jpg GRAPHIC 86753
50 adc-20201231_g8.jpg GRAPHIC 56880
51 adc-20201231_g9.jpg GRAPHIC 94834
52 image_01.jpg GRAPHIC 13509
  Complete submission text file 0001771910-21-000010.txt   30230723

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adc-20201231.xsd EX-101.SCH 157994
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adc-20201231_cal.xml EX-101.CAL 158878
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adc-20201231_def.xml EX-101.DEF 568273
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adc-20201231_lab.xml EX-101.LAB 1212263
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adc-20201231_pre.xml EX-101.PRE 828728
53 EXTRACTED XBRL INSTANCE DOCUMENT adc-20201231_htm.xml XML 3644704
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39071 | Film No.: 21753072
SIC: 2834 Pharmaceutical Preparations